Advantagene Announces Clinical Trial Collaboration
27 avr. 2018 07h00 HE
|
Advantagene, Inc.
AUBURNDALE, Mass., April 27, 2018 (GLOBE NEWSWIRE) -- Advantagene, Inc. today announced that the company entered into a clinical trial collaboration with Bristol-Myers Squibb (NYSE:BMY) to evaluate...